| Kunal D Kanitkar, MD | |
|
340 W Butler St, Lexington, SC 29072-2606 | |
| (803) 359-8777 | |
| (803) 359-1513 |
| Full Name | Kunal D Kanitkar |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 24 Years |
| Location | 340 W Butler St, Lexington, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639210925 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 24113 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Prisma Health Baptist Parkridge | Columbia, SC | Hospital |
| Lexington Medical Center | West columbia, SC | Hospital |
| Prisma Health Baptist | Columbia, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Palmetto Ophthalmology Associates Pa | 8628973922 | 8 |
News Archive
Home Diagnostics, Inc., a leading manufacturer and marketer of diabetes testing supplies, announced today that it signed a definitive merger agreement with Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086), a global manufacturer and distributor of medical devices, pharmaceutical products and medical and glass products headquartered in Osaka, Japan, under which Nipro will acquire all outstanding shares of Home Diagnostics' common stock, $.01 par value, for a cash purchase price of $11.50 per share (or aggregate consideration of approximately $215 million).
A new study shows that people tend to sleep faster and even achieve better quality sleep if they are gently swayed. The findings may explain why parents instinctively rock babies to sleep, and why we find it so easy to nod off when slumped in a rocking chair, they add
House calls, once thought to be too time-consuming and not very cost-effective, are making a comeback as health care providers recognize that they're actually the answer to good care for patients who can't make it to a doctor's office. Medicare-paid house calls have been steadily increasing, according to government figures, and doctors report the same for non-Medicare patients, according to the American Academy for Home Care Physicians.
Cell Therapeutics, Inc. announced today that the U.S. Food and Drug Administration's Oncologic Drugs Advisory Committee panel voted unanimously that clinical trial data was not adequate to support approval of pixantrone for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.
› Verified 1 days ago
| Entity Name | Palmetto Ophthalmology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275580805 PECOS PAC ID: 8628973922 Enrollment ID: O20031201000245 |
News Archive
Home Diagnostics, Inc., a leading manufacturer and marketer of diabetes testing supplies, announced today that it signed a definitive merger agreement with Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086), a global manufacturer and distributor of medical devices, pharmaceutical products and medical and glass products headquartered in Osaka, Japan, under which Nipro will acquire all outstanding shares of Home Diagnostics' common stock, $.01 par value, for a cash purchase price of $11.50 per share (or aggregate consideration of approximately $215 million).
A new study shows that people tend to sleep faster and even achieve better quality sleep if they are gently swayed. The findings may explain why parents instinctively rock babies to sleep, and why we find it so easy to nod off when slumped in a rocking chair, they add
House calls, once thought to be too time-consuming and not very cost-effective, are making a comeback as health care providers recognize that they're actually the answer to good care for patients who can't make it to a doctor's office. Medicare-paid house calls have been steadily increasing, according to government figures, and doctors report the same for non-Medicare patients, according to the American Academy for Home Care Physicians.
Cell Therapeutics, Inc. announced today that the U.S. Food and Drug Administration's Oncologic Drugs Advisory Committee panel voted unanimously that clinical trial data was not adequate to support approval of pixantrone for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kunal D Kanitkar, MD 340 W Butler St, Lexington, SC 29072-2606 Ph: (803) 359-8777 | Kunal D Kanitkar, MD 340 W Butler St, Lexington, SC 29072-2606 Ph: (803) 359-8777 |
News Archive
Home Diagnostics, Inc., a leading manufacturer and marketer of diabetes testing supplies, announced today that it signed a definitive merger agreement with Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086), a global manufacturer and distributor of medical devices, pharmaceutical products and medical and glass products headquartered in Osaka, Japan, under which Nipro will acquire all outstanding shares of Home Diagnostics' common stock, $.01 par value, for a cash purchase price of $11.50 per share (or aggregate consideration of approximately $215 million).
A new study shows that people tend to sleep faster and even achieve better quality sleep if they are gently swayed. The findings may explain why parents instinctively rock babies to sleep, and why we find it so easy to nod off when slumped in a rocking chair, they add
House calls, once thought to be too time-consuming and not very cost-effective, are making a comeback as health care providers recognize that they're actually the answer to good care for patients who can't make it to a doctor's office. Medicare-paid house calls have been steadily increasing, according to government figures, and doctors report the same for non-Medicare patients, according to the American Academy for Home Care Physicians.
Cell Therapeutics, Inc. announced today that the U.S. Food and Drug Administration's Oncologic Drugs Advisory Committee panel voted unanimously that clinical trial data was not adequate to support approval of pixantrone for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.
› Verified 1 days ago
Mark S. Keisler, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 340 W Butler St, Lexington, SC 29072 Phone: 803-359-8777 Fax: 803-359-1513 | |
John R Walters, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 340 W Butler St, Lexington, SC 29072 Phone: 803-359-8777 Fax: 803-359-1513 | |
Dr. Gavin Wade Davis, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4723 Sunset Blvd Ste A, Lexington, SC 29072 Phone: 803-999-3937 | |
Edward Gustavo Mintz, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 100 Palmetto Park Blvd, Lexington, SC 29072 Phone: 803-806-0080 Fax: 803-356-0668 | |
Charles David Finley, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 100 Palmetto Park Blvd, Lexington, SC 29072 Phone: 803-806-0080 Fax: 803-356-0668 | |
Garner Johnson Wild, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 100 Palmetto Park Blvd, Lexington, SC 29072 Phone: 803-806-0080 Fax: 803-356-0668 |